Control Bionics Limited (ASX:CBL)

Revenue by Segment

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
Japan and other markets	125.19K	59.95K	14.46K	-	-
R&D	724.63K	952.13K	412.81K	-	-
North America (US)	5.68M	4.96M	4.89M	-	-
Corporate	-750.63K	-705.89K	-428.02K	-	-
Australia	1.26M	1.09M	1.23M	-	-
Sale of Assistive Communications Technology Systems	-	-	-	4.50M	4.09M
Total	7.04M	6.36M	6.11M	4.50M	4.09M

Revenue by Geography

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Jun 30, 2018
Australia	1.25M	1.04M	1.21M	1.09M	1.13M
North America	4.77M	4.25M	4.42M	3.41M	2.85M
Japan and Other Markets	125.19K	59.95K	-	-	-
Other	-	-	14.46K	-	-
Total	6.14M	5.35M	5.64M	4.50M	3.97M

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 28, 2026

Data Sources Report a data error